PDS Biotechnology Corp.

PDSB:NASDAQ

PDS Biotechnology is a clinical stage immuno-oncology company with a growing pipeline of clinical-stage immunotherapies to treat various HPV-associated cancers, including head and neck cancer, cervical and anal cancers.

streetwise book logo Streetwise Company Fact Sheet

2024/4/19 23:31:36

(PDSB:NASDAQ)

Streetwise Reports Articles

10/13/2022 - View Article
09/23/2022 - View Article